While myths about wildlife abound, most are patently false. Bats are not blind; big bears can’t climb trees and birds will not abandon a fledgling touched by a human, among other falsehoods.
These forward-looking statements include, without limitation, statements related to Caribou’s strategy, plans, and objectives, and expectations regarding its clinical and preclinical development ...
Caribou to present at 43 r d Annual J.P. Morgan ... including its expectations regarding plans to present or provide (i) ANTLER Phase 1 clinical trial data in H1 2025 from both the additional ...
CB-012 AMpLify Phase 1 trial in r/r AML completes dose level 3 with no DLTs; enrolling patients at dose level 4 -- -- CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected ...
To confirm the HLA matching strategy, Caribou is enrolling approximately 20 additional second-line large B cell lymphoma (2L LBCL) patients in the ongoing ANTLER Phase 1 clinical trial.
At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Caribou presented clinical data from the ongoing ANTLER Phase 1 clinical trial that indicated a single dose of CB-010 has ...